Search PubMed⌕ Search

PubMed · 15211751

Development of a new reference standard for microarray experiments.

Abstract

Often microarray studies require a reference to indirectly compare the samples under observation. References based on pooled RNA from different cell lines have already been described (here referred to as RNA-R), but they usually do not exhaustively represent the set of genes printed on a chip, thus requiring many adjustments during the analyses. A reference could also be generated in vitro transcribing the collection of cDNA clones printed on the microarray in use (here referred to as T3-R). Here we describe an alternative and simpler PCR-based methodology to construct a similar reference (Chip-R), and we extensively test and compare it to both RNA-R and T3-R. The use of both Chip-R and T3-R dramatically increases the number of signals on the slides and gives more reproducible results than RNA-R. Each reference preparation is also evaluated in a simple microarray experiment comparing two different RNA populations. Our results show that the introduction of a reference always interferes with the analysis. Indeed, the direct comparison is able to identify more up- or down-regulated genes than any reference-mediated analysis. However, if a reference has to be used, Chip-R and T3-R are able to guarantee more reliable results than RNA-R.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Francesco Gorreta, Dagania Barzaghi, Amy J VanMeter, Vikas Chandhoke, Luca Del Giacco. 2004. Development of a new reference standard for microarray experiments.. https://doi.org/10.2144/04366rr01

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Quality control of Harpagophytum procumbens and its related phytopharmaceutical products by means of NIR-FT-Raman spectroscopy.

NIR-FT-Raman spectroscopy was used for identification and quantification of harpagoside in secondary roots of Harpagophytum procumbens as well as in related phytopharmaceutical products, e.g., ethanolic extracts and tablets. Applied Raman mappings reveal the spatial distribution of this valuable iridoid glycoside within the different samples. The same technique can be used for quality control purposes beginning from the plant to its final products. Based on the obtained spectral data and reference HPLC values of harpagoside, a reliable multivariate calibration model was developed.

Calibration↗

Facile access to 154Eu, a new reference source for calibration in gamma ray spectrometry.

Europium-154 can be obtained as a by-product from the large-scale production of Samarium-153 and possesses attractive features (t1/2 8.592 yr; Egamma 0.12-1.6 MeV) for use as a reference source similar to 152Eu (t1/2 13.516 yr; Egamma 0.12-1.4 MeV), which is the gold standard for calibration in gamma ray spectrometry. Thermal neutron irradiation of 5mg of 98% enriched 153Sm2O3 target in the reactor led to approximately 200 GBq 153Sm and 1.26 MBq 154Eu. A typical batch control sample of 153SmCl3 solution and final radiopharmaceutical product formulation of 153Sm-phosphonate (153Sm-EDTMP) pooled together contained about 20% of total yield, requiring post decay disposal of 153Sm as radioactive waste. Such spent solutions pooled on quarterly basis led to availing 756 kBq of 154Eu. The radioactivity content and radionuclide purity (approximately 82%) of the recovered 154Eu sample were envisaged as adequate to prepare reference sources for calibration of gamma ray spectrometers. At present, one batch of 153Sm is handled per month at our institution, with the possibility for weekly processing in future. Access to approximately 3.5 MBq of 154Eu on quarterly basis is envisaged, apart from obviating the need for instituting steps to tackle disposal of the long-lived 154Eu in the spent solution. Up to 60-120 units of 20-100 kBq of 154Eu reference sources per year could thus be available by the proposed strategy.

Calibration↗

Rapid analysis of total plasma homocysteine by tandem mass spectrometry.

Elevated plasma homocysteine levels may be an independent risk factor for premature vascular disease. Early detection and population screening are warranted to recognise hyperhomocysteinemia and initiate homocysteine lowering therapy. Current methods for homocysteine analysis are time consuming, labor intensive and/or expensive. We developed a sensitive and fast method for homocysteine analysis based on tandem mass spectrometry that avoids the need for derivatization and preanalytical chromatography.

Calibration↗